South-East Asia (WHO region) vs Tajikistan: HIV-positive TB patients on ART (antiretroviral therapy)
South-East Asia (WHO region)
94.0%
in 2024
Tajikistan
100.0%
in 2024
South-East Asia (WHO region) rank
4th
Tajikistan rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- South-East Asia (WHO region)
- Tajikistan
How they compare
Tajikistan currently reports 100.0% against 94.0% in South-East Asia (WHO region), a difference of 6.0%.
That makes Tajikistan's figure about 1.1 times South-East Asia (WHO region)'s.
The two have swapped places 8 times across 17 shared years of data; in 2007 it was Tajikistan ahead.
South-East Asia (WHO region) ranks 4th and Tajikistan ranks 1st of 11 groups.
Across the 3 decades both report, South-East Asia (WHO region) averaged higher in 1 and Tajikistan in 1.
Head to head by decade
| Decade | South-East Asia (WHO region) | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36.0% | 36.0% | 0.0% | — |
| 2010s | 75.3% | 74.2% | 1.1% | South-East Asia (WHO region) |
| 2020s | 92.2% | 97.8% | 5.6% | Tajikistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), South-East Asia (WHO region) or Tajikistan?
- Tajikistan, at 100.0% against 94.0% in South-East Asia (WHO region) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between South-East Asia (WHO region) and Tajikistan?
- 6.0%, with Tajikistan ahead.
- How many years of comparable data are there for South-East Asia (WHO region) and Tajikistan?
- 17 years are reported by both, from 2007 to 2024.
- How do South-East Asia (WHO region) and Tajikistan rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- South-East Asia (WHO region) ranks 4th and Tajikistan ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.